PEPMED
DEAD

Serial Number

76447468

Owner

Jerini AG

Attorney

Matthew J. Smith

Filing Date

Sep 5, 2002

Add to watchlist:

No watchlists yet
View on USPTO

PEPMED Trademark

Serial Number: 76447468 • Registration: 2870897

PEPMED is a trademark filed by Jerini AG on September 5, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Jerini AG (9 trademarks)

Friedrichstrasse 149
10117 Berlin , DE

Entity Type: 03

Trademark Details

Filing Date

September 5, 2002

Registration Date

August 10, 2004

Published for Opposition

May 18, 2004

Cancellation Date

March 11, 2011

Goods & Services

Custom synthesis of chemicals used in industry and science for third parties; custom immobilization of arrays of chemicals compounds for others; custom modification of peptides and proteins for others; and custom transformation of chemical compounds for others

Scientific measuring and checking apparatus and instruments, namely micro-array scanner comprised of filters and cellulose or polypropylene membranes for use in the field of biotechnology, pharmacology and for use in pharmaceutical research; analytical device, namely robot, synthesizer, spotter and nanoplotter for non-medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds

Human and veterinary pharmaceutical preparations for the treatment of illnesses caused by defects in signal transduction cascades, namely cancer, neurodegenerative diseases, allergic diseases and cardiovascular diseases, comprised of amino acids, nucleic acids, peptides, proteins and peptidomimetics; carrier materials comprised of nucleic acids, peptides and proteins for diagnostic purposes for medical treatments

Chemicals for use in the manufacture of pharmaceuticals; carrier materials comprised of nucleic acids, peptides and proteins for research purposes, for pharmaceutical research, for diagnostic purposes for scientific research, for biochemical research purposes in the field of antibody epitope mapping, proteine/proteine interaction, and enzyme profiling

Human and veterinary medical services; pharmaceutical advice; physician services; veterinary services

Analytical device, namely nanoplotter for medical purposes, comprised primarily of computer programs for synthesis and immobilization of chemicals, for the analysis of patterns on surfaces, and for the screening of chemical compounds

Scientific research, namely immobilization of arrays of chemical compounds, modification of peptides and proteins, transformation of chemical compounds; scientific and technological services and research as well as designer services for third parties in the field of biotechnology and pharmaceuticals, namely development of new technology for others; industrial analysis and research services in the field of biotechnology and pharmaceuticals, namely synthesis and immobilization of chemicals used in industry and science, screening for interaction partners, antibody epitope mapping, proteine/proteine interaction, and enzyme profiling; design and development of computer hardware and software; scientific research in the field of synthesis and immobilization of chemicals use in industry and science; chemical research, namely screening for chemical interactions of enzymes, enzyme substrates, antigens and antibodies; development of inhibitors of receptors and enzymes, namely, kinases, oxydoreductases, transerases, hydrolases, lyases, isomerases, and ligases; research and development of diagnostic assays, assays for pharmaceutical drug discovery and assays for target validation, namely methods for antigene detection and enzyme substrate identification for others; product research and development of chemicals used in industry and science; computer programming for other for the herein aforementioned purposes; agricultural research; scientific research; industrial design; computer programming for others; chemist, biologist, biochemist, gene technologist, molecular biologist, pharmacology, and physicist services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 22, 2011 TCCA
CANCELLED SEC. 8 (6-YR)
Mar 11, 2011 C8..
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2010 REAP
REVIEW OF CORRESPONDENCE COMPLETE
Oct 24, 2007 CORV
PAPER RECEIVED
Oct 18, 2007 MAIL
EXPARTE APPEAL TERMINATED
Aug 11, 2004 EXPT
REGISTERED-PRINCIPAL REGISTER
Aug 10, 2004 R.PR
PAPER RECEIVED
Jun 18, 2004 MAIL
PUBLISHED FOR OPPOSITION
May 18, 2004 PUBO
NOTICE OF PUBLICATION
Apr 28, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2004 CNSA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 24, 2004 JURT
EX PARTE APPEAL-INSTITUTED
Feb 24, 2004 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Feb 23, 2004 EXAF
FINAL REFUSAL MAILED
Aug 26, 2003 CNFR
Sec. 1(B) CLAIM DELETED
Aug 19, 2003 1.BD
CASE FILE IN TICRS
Aug 6, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2003 CRFA
PAPER RECEIVED
Jun 9, 2003 MAIL
ASSIGNED TO EXAMINER
Jan 6, 2003 DOCK
NON-FINAL ACTION MAILED
Dec 9, 2002 CNRT
ASSIGNED TO EXAMINER
Dec 9, 2002 DOCK
ASSIGNED TO EXAMINER
Nov 26, 2002 DOCK